Labcorp Holdings (LH) Earnings Analysis

Labcorp Holdings (LH) next reports earnings on 2026-07-30, consensus EPS 4.79 USD. Last quarter (2026-04-30) it beat with EPS 4.25 USD vs 4.11 USD est (+3.4%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 24.75.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does LH next report earnings?

Next earnings date2026-07-30
Consensus EPS estimate4.79 USD
Revenue estimate3.71B

LH earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-304.25 USD4.11 USD+3.4%Beat
2026-02-174.07 USD3.95 USD+3%Beat
2025-07-244.35 USD4.17 USD+4.3%Beat
2025-02-063.45 USD3.39 USD+1.8%Beat
2024-10-243.5 USD3.47 USD+0.9%Beat
2024-08-013.94 USD3.78 USD+4.2%Beat

Beat rate: 6/6 (100%) over reported quarters with consensus data.

LH valuation and analyst view

Trailing P/E24.75
Trailing EPS11.44 USD
Price / book2.65
Dividend yield1.02%
Market cap22.95B
Analyst consensusBuy (26 buy / 9 hold / 0 sell)
Avg price target334 USD

Related research pages

Frequently asked questions

When is Labcorp Holdings (LH)'s next earnings date?

Labcorp Holdings is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 4.79 USD and revenue estimate of 3.71B.

Did LH beat earnings last quarter?

In its 2026-04-30 report, LH posted EPS of 4.25 USD versus a 4.11 USD estimate — a beat of 3.4%.

What is LH's earnings track record?

Over the last 6 reported quarters with consensus data, LH beat estimates 6 times (100%).

What is LH's current P/E ratio and EPS?

LH trades at a trailing P/E of 24.75 on trailing EPS of 11.439854191980558 USD.

What do analysts rate LH?

Analyst consensus is "Buy" across 35 ratings (0 strong buy, 26 buy, 9 hold, 0 sell, 0 strong sell). Average 12-month price target: 334 USD.